Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18245 | Zandelisib | 1 | Active Not Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18245 | Zandelisib | 1 | Active Not Recruiting | 1 |